18 June 2013
Keywords: gilead, discontinues, development, gs, sciences, usa, says
Article | 01 November 2004
Gilead Sciences of the USA says it is discontinuing its development programs for GS 9005 and GS 7340, two investigational products for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 November 2004
17 June 2013
© 2013 thepharmaletter.com